PubRank

Bjarne Bogen

Author PubWeight™ 55.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 2006 3.07
2 Primary antitumor immune response mediated by CD4+ T cells. Immunity 2005 2.72
3 Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun 2011 1.49
4 Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type. J Immunol 2011 1.39
5 Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target. J Immunol 2003 1.13
6 A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease. PLoS One 2012 1.07
7 Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells. J Immunol 2005 1.05
8 Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. J Exp Med 2007 1.05
9 Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells. Cancer Res 2009 1.03
10 Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells. Cell Rep 2013 1.02
11 Delivery of antigen to CD40 induces protective immune responses against tumors. J Immunol 2007 1.01
12 The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma. Br J Haematol 2012 1.00
13 Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma. PLoS One 2012 0.96
14 Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences. Blood 2007 0.94
15 Monoclonal antibodies produced by muscle after plasmid injection and electroporation. Mol Ther 2004 0.93
16 Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies. Blood 2003 0.93
17 MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production. J Immunol 2004 0.93
18 A mouse C kappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation. Int Immunol 2002 0.93
19 Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus. Eur J Immunol 2014 0.93
20 TLR3-responsive, XCR1+, CD141(BDCA-3)+/CD8α+-equivalent dendritic cells uncovered in healthy and simian immunodeficiency virus-infected rhesus macaques. J Immunol 2014 0.91
21 DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells. Mol Ther 2006 0.91
22 Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis. J Leukoc Biol 2004 0.90
23 Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model. BMC Cancer 2011 0.88
24 Indirect CD4+ T-cell-mediated elimination of MHC II(NEG) tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells. Eur J Immunol 2014 0.87
25 The cellular mechanism by which complementary Id+ and anti-Id antibodies communicate: T cells integrated into idiotypic regulation. Immunol Cell Biol 2010 0.86
26 Expanding the versatility of phage display II: improved affinity selection of folded domains on protein VII and IX of the filamentous phage. PLoS One 2011 0.86
27 Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma. Immunol Lett 2013 0.86
28 DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza. J Immunol 2013 0.85
29 A model for cancer-suppressive inflammation. Oncoimmunology 2012 0.85
30 Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells. Front Oncol 2012 0.84
31 Molecular profiling of tumor-specific TH1 cells activated in vivo. Oncoimmunology 2013 0.84
32 Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems. Am J Pathol 2009 0.84
33 Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice. Blood 2012 0.83
34 Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing. Eur J Haematol 2011 0.82
35 Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies. J Immunol 2002 0.82
36 The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype. PLoS One 2013 0.82
37 Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma. J Clin Invest 2015 0.82
38 Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines. Vaccine 2010 0.82
39 Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display. Sci Rep 2013 0.81
40 Human receptors of innate immunity (CD14, TLR2) are promising targets for novel recombinant immunoglobulin-based vaccine candidates. Vaccine 2007 0.81
41 CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo. Cancer Immunol Immunother 2004 0.81
42 Expression of SH2D2A in T-cells is regulated both at the transcriptional and translational level. Mol Immunol 2007 0.79
43 A VH4-34+ myeloma protein with weak autoreactivity. Haematologica 2007 0.78
44 Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models. Cancer Immunol Immunother 2004 0.78
45 Heterodimeric barnase-barstar vaccine molecules: influence of one versus two targeting units specific for antigen presenting cells. PLoS One 2012 0.78
46 Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells. Eur J Immunol 2005 0.78
47 Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA. BMC Biotechnol 2010 0.78
48 Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules. Expert Rev Vaccines 2015 0.78
49 DeltaPhage--a novel helper phage for high-valence pIX phagemid display. Nucleic Acids Res 2012 0.77
50 Expanding the versatility of phage display I: efficient display of peptide-tags on protein VII of the filamentous phage. PLoS One 2011 0.77
51 CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses. Protein Eng Des Sel 2012 0.77
52 Processing of an antigenic sequence from IgG constant domains for presentation by MHC class II. J Immunol 2008 0.77
53 Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes. Eur J Immunol 2005 0.76
54 SH2D2A modulates T cell mediated protection to a B cell derived tumor in transgenic mice. PLoS One 2012 0.76
55 Antibody-mediated delivery of antigen to chemokine receptors on antigen-presenting cells results in enhanced CD4+ T cell responses. Eur J Immunol 2003 0.76
56 Stabilizing mutations increase secretion of functional soluble TCR-Ig fusion proteins. BMC Biotechnol 2010 0.76
57 The idiotype connection: linking infection and multiple sclerosis. Trends Immunol 2009 0.76
58 Recombinant antibodies for delivery of antigen: a single loop between beta-strands in the constant region can accommodate long, complex and tandem T cell epitopes. Int Immunol 2008 0.76
59 Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice. J Transl Med 2014 0.75
60 [DNA--the future in vaccine technology?]. Tidsskr Nor Laegeforen 2006 0.75
61 B-cell tolerance to the B-cell receptor variable regions. Eur J Immunol 2013 0.75
62 Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes. J Leukoc Biol 2004 0.75
63 Naive idiotope-specific B and T cells collaborate efficiently in the absence of dendritic cells. J Immunol 2014 0.75